Tafasitamab 12714-0219-40

Package NDC

12714-0219-40

Product NDC: 12714-0219

Manufacturer: Boehringer Ingelheim Pharma Gmbh And Co. Kg
Dosage Form: Powder
Product Type: Drug For Further Processing
Marketing Start: July 31, 2020
Listing Expires: December 31, 2026

Active Ingredients

Ingredient	Strength
Tafasitamab	200 mg/200mg

Selected Package

12714-0219-40Selected

1.3 mg in 1 VIAL, SINGLE-DOSE (12714-219-40)

Related Products

All Tafasitamab NDC codes →

External Resources

FDA Drug Database DailyMed Label